INVO Bioscience, Inc. (INVO)
NASDAQ: INVO · IEX Real-Time Price · USD
0.747
-0.024 (-3.08%)
At close: Jul 19, 2024, 4:00 PM
0.793
+0.046 (6.14%)
Pre-market: Jul 22, 2024, 7:30 AM EDT
Company Description
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide.
It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body.
The company was founded in 2007 and is based in Sarasota, Florida.
INVO Bioscience, Inc.
| Country | United States |
| Founded | 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 30 |
| CEO | Steven M. Shum |
Contact Details
Address: 5582 Broadcast Court Sarasota, Florida 34240 United States | |
| Phone | (978) 878-9505 |
| Website | invobio.com |
Stock Details
| Ticker Symbol | INVO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001417926 |
| CUSIP Number | 44984F302 |
| ISIN Number | US44984F4019 |
| Employer ID | 20-4036208 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Steven M. Shum | Chief Executive Officer and Director |
| Andrea Goren | Chief Financial Officer |
| Michael Jos. Campbell | Chief Operating Officer and Vice President of Business Development |
| Bojan Mitrovic Ph.D. | Director of Sales US |
| Robert Joseph Bowdring Jr. | Treasurer and Secretary |
| Terah Krigsvold | Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 5, 2024 | 8-K | Current Report |
| Jun 20, 2024 | 8-K | Current Report |
| May 21, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| May 15, 2024 | 8-K | Current Report |
| May 15, 2024 | 10-Q | Quarterly Report |
| May 6, 2024 | 8-K | Current Report |
| Apr 29, 2024 | 10-K/A | [Amend] Annual report |
| Apr 19, 2024 | 8-K | Current Report |
| Apr 17, 2024 | 10-K/A | [Amend] Annual report |
| Apr 17, 2024 | 8-K | Current Report |